This article demonstrates liquid biopsy improves disease detection by analyzing cell-free DNA and extracellular vesicles.
Liquid biopsy has emerged as a transformative, minimally invasive strategy for disease detection and longitudinal monitoring through the analysis of circulating molecular components, including cell-free DNA (cfDNA), cell-free RNA, extracellular vesicles, and circulating proteins in bodily fluids.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: